Туберкулез и болезни лёгких (Sep 2022)

Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host

  • G. N. Mozhokina,
  • A. G. Samoylova,
  • I. A. Vasilyeva,
  • A. E. Russkikh

DOI
https://doi.org/10.21292/2075-1230-2022-100-8-54-64
Journal volume & issue
Vol. 100, no. 8
pp. 54 – 64

Abstract

Read online

The review presents up-to-date data from 88 publications devoted to the short-course regimens of multiple drug resistant tuberculosis treatment and describes characteristics of the most effective drugs – bedaquiline, linezolid, delamanid, and clofazimine. Information is also provided on the additional properties of the drugs, i.e. modulation of the key immune response and immunometabolic processes that underlie a new approach to improvement of tuberculosis treatment, the so-called host therapy.

Keywords